The Treatment Of Heart Transplant Essay

A heart transplant is an operation in which a failing heart is replaced with a healthier donor heart, it has many, many risk but could also save your life (heart). The heart is about the size of an adult fist. The heart is located behind the breast bone(transplant). The heart pumps deoxygenated blood that flows from the heart to the lungs, that give off carbon dioxide and freshly oxygenated (Transplant).

Patients who underwent this procedure had to remain on immunosuppressive drugs for about 6 months to prevent the recipient’s immune system from destroying the donor cell. One out of seven patients that had this procedure done had a relapse because they stopped taking their immunosuppressant drug during the critical stage of treatment. This treatment has proven successful, but there still remains the concern of tissue rejection and other complication. Nevertheless, this approach still provides encouragement for people suffering with the disease.

Rejection can't be totally avoided; nonetheless, a level of safe resilience to the transplant develops. A few ideas have been proposed to clarify the advancement of halfway resistance. They incorporate clonal erasure and the advancement of anergy in benefactor particular lymphocytes, improvement of silencer lymphocytes, or variables that down-direct the insusceptible reaction against the join. Different speculations incorporate the steadiness of benefactor determined dendritic cells in the beneficiary that advance an immunologically interceded chimeric state between the beneficiary and the transplanted

In order for transplants to be successful, there are steps that should be followed. From the beginning, the correct information should be given prior to

Feedback: The use of cyclosporine to protect the patient from rejection of the heart places the patient in an immunosuppressive state. The nurse should instruct on frequent

Another health problem that treatment with embryonic stem cells can cause is tissue rejection. As is the case with current organ transplantation procedures, embryonic stem cells are harvested from many people all who possess a unique set of genes; therefore, the stem cells are not genetically matched for each patient (Herold 48-49). The difference in genetics causes the body to reject the tissue and the immune system begins to attack the transplanted tissue like it would a virus or bacteria in an attempt to remove the perceived threat. To avoid the implanted tissues being rejected by the body, doctors must prescribe immune suppression drugs that must be taken for the remainder of the patient’s life, even with these drugs the tissue may still be rejected and

Congenital heart disease (CHD) is one of the most common birth defects found in children, with an incidence of approximately nine in every 1000 live births worldwide (van der Linde et al., 2011). Children with complex CHD are living longer due to dramatic advances in medical procedures and surgical techniques (Berger et al., 2017), as well as the increase in number of pediatric heart transplant recipients over the past two decades (U.S. Department of Health & Human Services, 2017), and the decrease in the death rates from CHD, with this population now living into adulthood (Pillutla, Shetty, & Foster, 2008). Costs related to the care of children with CHD are greater than $5.6 billion dollars a year, with an average hospitalization costing

The other challenge to transplanting organs is the body’s immune system rejecting the procedure because it is unnatural to it. The body’s immune system is set up to defend the body against any foreign disease-causing bacteria, viruses and or fungi. A procedure like this is alienated by the body at time because it

The demand for an organ transplant continues to grow and when an organ becomes available there are multiple precautions to take to make sure the body does not reject the organ. The certain anti-rejection (immunosuppressant) medication that needs to be taken before a transplant to decrease the body’s immune response from attacking a foreign object (the transplant organ). The medication also lowers the immune system. Therefore, the immune system does not cause the body to reject the organ. Statists have shown, that up twenty percent of patients that get an organ transplant, experience one out of the three organ rejections.

The Donor Alliance Transplantation Science program has enjoyed incredible success during the past five years – the number of students reached has doubled and the program has received praise for its content and presentation. However, there is room for improvement and overcoming potential issues.

There are many cases of allogeneic organ transplants being susceptible to rejection by being attacked by the recipient's immune system. Growing an organ from human tissue in another species increases the chances of rejection and might lead to several other complications that have not yet been considered nor are fully understood.

Often when a patient is waiting for an organ transplant finding the donor could take months. Unfortunately, most patrons on the organ donation list may not have enough time left to wait several months and in fact some never reach the day they would receive their transplant. An “average of 22 people die each day waiting for transplants that can't take place because of the shortage of donated organs” (The Need Is Real: Data). This is where cloning would become extremely beneficial in the medical field. Finding a donor can take so much time because they must be in good mental and physical health, which means they are free of any health issues with their mind or body, and that they must be willing to donate. Then after passing these criteria the donor must test for being a possible match. Matching is the most difficult part of being a donor, but with cloning, that can change. By creating the exact copy of the organ, we can get rid of transplant rejection. Transplant rejection is when the matched donor transplants the organ and the patient’s body rejects the organ causing your own immune system to attack the new organ, the rejection can be dangerous and can sometimes be fatal. By cloning the organs instead “blood type, tissue type, height, and weight. The length of time the patient has been waiting, the severity of the patient's illness” (Organ Donation: The

Graft rejection: Type IV hypersensitivity. Type IV hypersensitivity is a delayed hypersensitivity as the reaction takes more than 12 hours. It is mediated by T helper cells and cytotoxic T cells and does not involved antibodies. In graft rejection, the rejection is caused by foreign MHC antigens as the T cells responds to them by attacking the foreign MHC antigens when they are being recognized. Rejection also only takes place after a few hours to months and years depending on the type of

As the site content was developed it was apparent that age appropriate information was needed for the child receiving the transplant regarding their diagnosis and treatment. Information was also needed for the siblings of a transplant recipient. Previously, the website gave an in-depth detailed description of adult transplant preparation, but did not give explanations for pediatric patients. Grouping children into age categories (preschool, children ages 6-12, and teenagers) enabled the information regarding transplant basics and preparation to be tailored to a child’s specific developmental level. Creating age groups made the information more concise, and clearly told the parent of a child getting a transplant what actions to take (CDC, 2010).

When dealing with a cardiovascular disorder, a child’s heart has to work harder in order for that child to be able to accomplish everyday tasks. Heart disease is not a major cause of death in children, but it is the number one cause of death among adults in the United States. It is silly, and even worse, sad to see a life taken away by a condition that could have been prevented.